New England Research & Management Lifted Agilent (A) Holding By $339,900; Chemical Bank Lowered Pfizer (PFE) Holding

Pfizer Inc. (NYSE:PFE) Logo

Chemical Bank decreased Pfizer Inc (PFE) stake by 5.16% reported in 2017Q4 SEC filing. Chemical Bank sold 14,305 shares as Pfizer Inc (PFE)’s stock declined 3.13%. The Chemical Bank holds 262,917 shares with $9.52M value, down from 277,222 last quarter. Pfizer Inc now has $217.30 billion valuation. The stock increased 0.11% or $0.04 during the last trading session, reaching $36.53. About 15.78M shares traded. Pfizer Inc. (NYSE:PFE) has risen 2.43% since April 20, 2017 and is uptrending. It has underperformed by 9.12% the S&P500.

New England Research & Management Inc increased Agilent (A) stake by 79.23% reported in 2017Q4 SEC filing. New England Research & Management Inc acquired 5,150 shares as Agilent (A)’s stock declined 0.52%. The New England Research & Management Inc holds 11,650 shares with $780,000 value, up from 6,500 last quarter. Agilent now has $21.92B valuation. The stock decreased 2.27% or $1.58 during the last trading session, reaching $67.97. About 2.44M shares traded. Agilent Technologies, Inc. (NYSE:A) has risen 25.85% since April 20, 2017 and is uptrending. It has outperformed by 14.30% the S&P500.

Among 15 analysts covering Agilent Technologies (NYSE:A), 11 have Buy rating, 0 Sell and 4 Hold. Therefore 73% are positive. Agilent Technologies has $91 highest and $5 lowest target. $70.36’s average target is 3.52% above currents $67.97 stock price. Agilent Technologies had 58 analyst reports since August 14, 2015 according to SRatingsIntel. As per Thursday, January 7, the company rating was initiated by Deutsche Bank. The firm has “Buy” rating by Bank of America given on Tuesday, August 15. As per Wednesday, September 20, the company rating was maintained by Jefferies. The company was maintained on Thursday, February 15 by JP Morgan. The firm earned “Buy” rating on Wednesday, August 9 by Jefferies. Robert W. Baird maintained Agilent Technologies, Inc. (NYSE:A) rating on Thursday, January 18. Robert W. Baird has “Buy” rating and $76.0 target. The firm has “Buy” rating given on Thursday, August 18 by Goldman Sachs. On Tuesday, August 25 the stock rating was downgraded by TheStreet to “Buy”. The firm has “Outperform” rating by Cowen & Co given on Thursday, May 26. The firm earned “Buy” rating on Wednesday, August 16 by J.P. Morgan.

New England Research & Management Inc decreased Estee Lauder (NYSE:EL) stake by 3,325 shares to 2,700 valued at $344,000 in 2017Q4. It also reduced Martin Marietta Materials Inc (NYSE:MLM) stake by 2,050 shares and now owns 4,150 shares. Abbvie Inc. (NYSE:ABBV) was reduced too.

Since December 18, 2017, it had 0 insider buys, and 9 selling transactions for $9.10 million activity. 5,000 shares were sold by FIELDS HEIDI, worth $340,450 on Tuesday, March 27. Kaltenbach Patrick sold $490,738 worth of Agilent Technologies, Inc. (NYSE:A) on Monday, March 12. 2,441 shares were sold by Doak Mark, worth $173,311. Shares for $1.58M were sold by McMullen Michael R. on Thursday, January 18. Gonsalves Rodney had sold 6,825 shares worth $486,145 on Tuesday, March 13.

Investors sentiment decreased to 0.95 in Q4 2017. Its down 0.45, from 1.4 in 2017Q3. It dived, as 40 investors sold A shares while 198 reduced holdings. 62 funds opened positions while 164 raised stakes. 269.93 million shares or 0.89% more from 267.56 million shares in 2017Q3 were reported. Creative Planning reported 17,113 shares or 0% of all its holdings. Aperio Ltd Liability holds 0.1% or 288,093 shares in its portfolio. Cardinal Capital holds 63,714 shares or 1.29% of its portfolio. Kingfisher Ltd Liability Corp holds 0.9% or 21,251 shares. Cambridge Tru holds 15,893 shares or 0.07% of its portfolio. 665 are owned by Northwestern Mutual Wealth Mgmt. Prudential Public Limited Company invested 0% of its portfolio in Agilent Technologies, Inc. (NYSE:A). Sandy Spring Comml Bank has invested 0.01% of its portfolio in Agilent Technologies, Inc. (NYSE:A). Federated Pa has 312,639 shares for 0.06% of their portfolio. Daiwa Grp has 0% invested in Agilent Technologies, Inc. (NYSE:A). Los Angeles Mgmt & Equity Research owns 622,719 shares or 0.23% of their US portfolio. Parkside Comml Bank And Trust holds 0.01% or 209 shares in its portfolio. Coastline Tru stated it has 24,695 shares or 0.25% of all its holdings. Financial Professionals reported 7 shares or 0% of all its holdings. Prelude Capital Mngmt Ltd Liability reported 15 shares or 0% of all its holdings.

Chemical Bank increased Wisdomtree Us Midcap Dividend (DON) stake by 15,098 shares to 20,008 valued at $706,000 in 2017Q4. It also upped Weyerhaeuser Co Reit (NYSE:WY) stake by 10,070 shares and now owns 27,509 shares. Vanguard Total Stock Market Et (VTI) was raised too.

Since December 15, 2017, it had 0 insider buys, and 12 selling transactions for $12.99 million activity. 69,699 shares were sold by Dolsten Mikael, worth $2.55M. HILL CHARLES H sold $986,292 worth of stock or 26,779 shares. MACKENZIE ALEXANDER R sold $249,750 worth of Pfizer Inc. (NYSE:PFE) on Friday, December 15. 27,323 shares were sold by JOHNSON RADY A, worth $998,666. LANKLER DOUGLAS M had sold 50,000 shares worth $1.84 million. 1,758 shares were sold by CORNWELL W DON, worth $64,679 on Monday, February 26. LUND-JURGENSEN KIRSTEN sold 9,510 shares worth $353,677.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on May, 1 before the open. They expect $0.73 EPS, up 5.80% or $0.04 from last year’s $0.69 per share. PFE’s profit will be $4.34 billion for 12.51 P/E if the $0.73 EPS becomes a reality. After $0.62 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts 17.74% EPS growth.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart